Patient reported outcomes (PRO) during and after multimodal treatment for resectable esophageal adenocarcinoma in the prospective, randomized, controlled, multicenter phase III ESOPEC trial.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Join the Tom's Guide Club for quick access. Enter your email below and we'll send confirmation, and sign you up to our newsletter.
We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Crypto.com is the clear winner, with lower fees and extensive array of earning ...
John Edwards is a licensed attorney with experience in commodities and investments. He provides performance analysis of hedge funds and investors. An LLC offers flexibility in management and tax ...
Kale and spinach are both packed with vitamins and minerals and offer several health benefits. Kale is richer in vitamin C, while spinach has more folate and vitamins A and K. Both are rich in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results